secwatch.observer — SEC 8-K summary
======================================

Issuer:     Relay Therapeutics, Inc. (RLAY)
CIK:        0001812364
Form:       8-K
Filed at:   2022-09-15T23:59:59+00:00
Accession:  0000950170-22-018514
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Relay Therapeutics prices $300M public offering of 11.32M shares at $26.50 per share
--------------------------------------------------------------------------------

- Priced public offering of 11,320,755 shares at $26.50/share; gross proceeds ~$300M.
- Net proceeds expected ~$284.5M after underwriting discounts and expenses.
- Underwriters granted 30-day option to buy up to 1,698,113 additional shares.
- Offering expected to close on September 15, 2022; Goldman Sachs, J.P. Morgan, Cowen, BofA act as managers.
- All shares sold by Relay Therapeutics; shelf registration effective.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812364/000095017022018514/0000950170-22-018514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812364/000095017022018514/rlay-20220912.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-018514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer